![Daniel Deardorf](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Daniel Deardorf is currently Chief Executive Officer & Director at Glycologix, Inc. Formerly, Mr. Deardorf was Senior Vice President-Commercial at Flexion Therapeutics, Inc.
Actieve functies van Daniel Deardorf
| Bedrijven | Functie | Begin |
|---|---|---|
Glycologix, Inc.
 Glycologix, Inc. BiotechnologyHealth Technology Operates as an innovative clinical-stage biotechnology company that develops locally delivered biopolymers aimed at the protection and repair of soft tissues | Algemeen Directeur | 01-01-2021 |
Eerdere bekende functies van Daniel Deardorf
| Bedrijven | Functie | Einde |
|---|---|---|
| FLEXION THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
1
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Glycologix, Inc.
Glycologix, Inc. BiotechnologyHealth Technology Operates as an innovative clinical-stage biotechnology company that develops locally delivered biopolymers aimed at the protection and repair of soft tissues | Health Technology |
